Description
An inhibitor of ceramide-specific glucosyltransferase and β-glucosidase 2 (IC50s = 32 and 81 μM, respectively, for rat recombinant enzymes); leads to a 2.1-, 1.3-, 2.3-, 3.6,- and 9.9-fold increase in the activity of wild-type, S364R, N370S, V15M, and M123t glucocerebrosidase in COS-7 cells; inhibits HIV-1 and HIV-2 infection of PBMCs (IC50s = 282 and 211 μM, respectively) ,
Formal name: 1-butyl-2R-(hydroxymethyl)-3R,4R,5S-piperidinetriol, monohydrochloride
Synonyms: Miglustat|NB-DNJ
Molecular weight: 255.7
CAS: 210110-90-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Small Molecule Inhibitors|Sphingolipid Turnover||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS||Research Area|Lipid Biochemistry|Sphingolipids